Home » Topics » BioWorld Science, Cardiovascular

BioWorld Science, Cardiovascular
RSS

Uriach describes antihypertensive activity and renal effects of AII blocker

Aug. 13, 1998

The peripheral vasodilator vintoperol has antioxidant action in vitro

Aug. 13, 1998

Endothelin ETA antagonist YM-598 undergoes preclinical testing at Yamanouchi

Aug. 13, 1998

Sumitomo proves cardioprotective activity of Na+/H+ exchange inhibitor SM-20550

Aug. 12, 1998

Profile of Solvay's dual NEP/ECE inhibitor in clinical testing

Aug. 12, 1998

Japanese scientists isolate CETP inhibitors from fungal source

Aug. 12, 1998

Intercardia sees potential conflict in its collaboration with Astra Merck

Aug. 12, 1998

Heart attack patients demonstrate elevated matrix metalloproteinase levels

Aug. 12, 1998

Acetaminophen may be useful for the treatment of atherosclerosis

Aug. 12, 1998

Dual ETA/ETB antagonist provides effective blood pressure control in rats

Aug. 11, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
Jingxin discloses new muscarinic and sigma receptor agonists
BioWorld Science
Shanghai Jingxin Biopharmaceutical Co. Ltd. and Zhejiang Jingxin Pharmaceutical Co. Ltd. have synthesized new muscarinic acetylcholine receptor and sigma receptor...